Figure 3From: Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia Relative five-year survival for breast cancer patients according to (A) localized disease (stage 1–2) or (B) metastatic disease (stage 3–4), and presence or absence of BRCA2 mutations (BRCA+/-).Back to article page